(Reuters) – The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc’s drug as a broad treatment for all heart failure patients, including adults with type 2 diabetes, the company said on Friday.
(Reporting by Khushi Mandowara and Mariam Sunny in Bengaluru; Editing by Shailesh Kuber)
